
|Articles|November 7, 2016
INC Research to Manage LLS Master Trial
INC Research announces its involvement in the Leukemia & Lymphoma Society’s (LLS) precision medicine Master Trial for the treatment of acute myeloid leukemia (AML).
Advertisement
INC Research announces its involvement in the Leukemia & Lymphoma Society’s (LLS) precision medicine Master Trial for the treatment of acute myeloid leukemia (AML). The trial will provide principal investigators and their patients consolidated access to test novel therapies matched to specific molecular aberrations in AML.
Read the full release
Advertisement
Advertisement
Advertisement
Trending on Applied Clinical Trials Online
1
AI-Driven Clinical Trial Recruitment and Design
2
What Clinical Trials Can Learn from the Gig Economy About Payments
3
PLPS Launches MyClinicalSuite™ to Deliver Faster Clinical Trial Label Turnarounds Without Compromising Quality, Compliance, or Patient Safety
4
ACT Brief: RBQM Financial Value Quantified, Sponsor-Configurable AI Systems, and Basket Trials for Rare Pediatrics
5




